Nu Skin Enterprises (NUS) Tops Q3 EPS by 5c; offers guidance

Nu Skin Enterprises (NYSE: NUS) reported Q3 EPS of $0.34, $0.05 better than the analyst estimate of $0.29. Revenue for the quarter came in at $364.2 million versus the consensus estimate of $366.12 million.

GUIDANCE:

Nu Skin Enterprises sees Q4 2025 EPS of $0.25-$0.35, versus the consensus of $0.33. Nu Skin Enterprises sees Q4 2025 revenue of $365-400 million, versus the consensus of $392.1 million.

Nu Skin Enterprises sees FY2025 EPS of $1.25-$1.35, versus the consensus of $1.26. Nu Skin Enterprises sees FY2025 revenue of $1.48-1.51 billion, versus the consensus of $1.517 billion.

For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.

You May Also Be Interested In

• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
• Enanta Pharma loses appeal in Pfizer Paxlovid patent case
• MoveSmart Rentals Opens Toronto Branch, Expanding Its Canadian Leasing Operations